×

Expect to see more politics in M&A: Pro

2:00 AM ET Fri, 9 May 2014

Larry Hatheway, chief economist at UBS Investment Bank, says the political involvement in Pfizer's bid for Astrazeneca will continue and there will be similar instances ahead.